Neuropeptide FF receptors as novel targets for limbic seizure attenuation.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neuropharmacology

• Publication date

  2015-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuropharm.2015.04.030PMID 25963417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors.

  2013cited by this paper
• Inactivation of the Constitutively Active Ghrelin Receptor Attenuates Limbic Seizure Activity in Rodents

  2012cited by this paper
• Direct guanidinylation of aryl and heteroaryl halides via copper-catalyzed cross-coupling reaction.

  2012cited by this paper
• Development of sub-nanomolar dipeptidic ligands of neuropeptide FF receptors.

  2012cited by this paper
• Structure–Activity Studies of RFamide Peptides Reveal Subtype‐Selective Activation of Neuropeptide FF1 and FF2 Receptors

  2011cited by this paper
• Central locomotor and cognitive effects of a NPFF receptor agonist in mouse.

  2010cited by this paper
• Opposite control of body temperature by NPFF1 and NPFF2 receptors in mice.

  2010cited by this paper
• Distribution of neuropeptide FF (NPFF) receptors in correlation with morphine-induced reward in the rat brain.

  2010cited by this paper
• Neuropeptide FF Receptors Have Opposing Modulatory Effects on Nociception

  2010cited by this paper
• Discovery of selective nonpeptidergic neuropeptide FF2 receptor agonists.

  2009cited by this paper
• Intrastrain differences in seizure susceptibility, pharmacological response and basal neurochemistry of Wistar rats.

  2009cited by this paper
• Anoretic effects of neuropeptide FF are mediated via central mu and kappa subtypes of opioid receptors and receptor ligands.

  2008cited by this paper
• Seizure activity and changes in hippocampal extracellular glutamate, GABA, dopamine and serotonin.

  2008cited by this paper
• Clinical potential of neuropeptide Y receptor ligands in the treatment of epilepsy.

  2007cited by this paper
• Sigma 1 receptor‐mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y

  2007cited by this paper
• Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y2 receptors

  2007cited by this paper
• Cecum location in rats and the implications for intraperitoneal injections

  2007cited by this paper
• Differential Actions of NPY on Seizure Modulation via Y1 and Y2 Receptors: Evidence from Receptor Knockout Mice

  2006cited by this paper
• Correction for Simonin et al., RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia

  2006cited by this paper
• Cardiovascular effects of neuropeptide FF antagonists.

  2006cited by this paper
• Substantia Nigra Is an Anticonvulsant Site of Action of Topiramate in the Focal Pilocarpine Model of Limbic Seizures

  2006cited by this paper
• Anti-analgesia of a selective NPFF2 agonist depends on opioid activity.

  2005cited by this paper
• Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists.

  2005cited by this paper
• Central Administration of Neuropeptide FF Causes Activation of Oxytocin Paraventricular Hypothalamic Neurones That Project to the Brainstem

  2003cited by this paper
• Neuropeptides: opportunities for drug discovery.

  2003cited by this paper
• Induced down‐regulation of neuropeptide Y‐Y1 receptors delays initiation of kindling

  2003cited by this paper
• Extracellular levels of NPY in the dorsal hippocampus of freely moving rats are markedly elevated following a single electroconvulsive stimulation, irrespective of anticonvulsive Y1 receptor blockade.

  2002cited by this paper
• Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists.

  2002cited by this paper
• Neuropeptide Y and epilepsy: varying effects according to seizure type and receptor activation.

  2001cited by this paper
• Intracerebroventricular injection of neuropeptide FF, an opioid modulating neuropeptide, acutely reduces food intake and stimulates water intake in the rat.

  2001cited by this paper
• Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in vivo.

  2001cited by this paper
• Highly selective and potent neuropeptide Y (NPY) Y1 receptor antagonists based on [Pro(30), Tyr(32), Leu(34)]NPY(28-36)-NH2 (BW1911U90).

  2001cited by this paper
• Identification and Characterization of Two G Protein-coupled Receptors for Neuropeptide FF*

  2000cited by this paper
• Plastic Changes in Neuropeptide Y Receptor Subtypes in Experimental Models of Limbic Seizures

  2000cited by this paper
• Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition.

  1999cited by this paper
• Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes.

  1999cited by this paper
• Anticonvulsant properties of BIBP3226, a non‐peptide selective antagonist at neuropeptide Y Y1 receptors

  1998cited by this paper
• NMDA receptor‐mediated pilocarpine‐induced seizures: characterization in freely moving rats by microdialysis

  1997cited by this paper
• Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors

  1997cited by this paper
• SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

  1997cited by this paper
• Neuropeptide FF reduces food intake in rats.

  1996cited by this paper
• Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam.

  1996cited by this paper
• Neuropeptide FF, a mammalian neuropeptide with multiple functions.

  1996cited by this paper
• Expression of the neuropeptide Y Y1 receptor in human embryonic kidney 293 cells: ligand binding characteristics, in situ hybridization and receptor autoradiography.

  1995cited by this paper
• Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.

  1995cited by this paper
• FMRF-amide and L-Arg-L-Phe increase blood pressure and heart rate in the anaesthetised rat by central stimulation of the sympathetic nervous system.

  1991cited by this paper
• Cloning and expression of a rat neuromedin K receptor cDNA.

  1990cited by this paper
• Direct excitatory effects of neuropeptide Y (NPY) on rat hippocampal neurones in vitro.

  1987cited by this paper
• Modification of seizure activity by electrical stimulation. II. Motor seizure.

  1972cited by this paper

• Transcriptomic Changes in Mouse Bone Marrow-Derived Macrophages Exposed to Neuropeptide FF

  2021cites this paper
• Cellular processes involved in RAW 264.7 macrophages exposed to NPFF: A transcriptional study.

  2020cites this paper
• The effect of neuropeptide FF in the amygdala kindling model

  2016cites this paper
• Chronic activation of NPFFR2 stimulates the stress-related depressive behaviors through HPA axis modulation.

  2016cites this paper